Works matching IS 02770008 AND DT 2025 AND VI 45 AND IP 1

Results: 10

Association of atrial fibrillation with lamotrigine: An observational cohort study.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 20, doi. 10.1002/phar.4633

By:

Kim, Sodam;
Welch, Landon;
Santos, Bertha De Los;
Radwański, Przemysław B.;
Munger, Mark A.;
Kim, Kibum

Publication type:

Article

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 4, doi. 10.1002/phar.4638

By:

Harris, Rachel D.;
Taylor, Olga A.;
Gramatges, M. Monica;
Hughes, Amy E.;
Zobeck, Mark;
Pruitt, Sandi;
Bernhardt, M. Brooke;
Chavana, Ashley;
Huynh, Van;
Ludwig, Kathleen;
Klesse, Laura;
Heym, Kenneth;
Griffin, Timothy;
Erana, Rodrigo;
Bernini, Juan Carlos;
Choi, Ashley;
Ohno, Yuu;
Richard, Melissa A.;
Morrison, Alanna C.;
Chen, Han

Publication type:

Article

Response to comment on "Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data".

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 71, doi. 10.1002/phar.4637

By:

Aparasu, Rajender R.;
Talwar, Ashna

Publication type:

Article

Comment on "Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data".

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 70, doi. 10.1002/phar.4636

By:

Wang, Shih‐Jie;
Wei, Lien‐Chung;
Chiu, Hsien‐Jane

Publication type:

Article

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 54, doi. 10.1002/phar.4635

By:

Garwood, Candice L.;
Cabral, Katherine P.;
Brown, Roy;
Dixon, Dave L.

Publication type:

Article

Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 33, doi. 10.1002/phar.4640

By:

Karanam, Ashwin;
Pennell, Page B.;
Meador, Kimford J.;
Long, Yuhan;
Birnbaum, Angela K.

Publication type:

Article

Pharmacokinetics of cefiderocol in a patient with carbapenem‐resistant Acinetobacter baumannii ventriculitis: A case report.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 66, doi. 10.1002/phar.4632

By:

Finch, Natalie A.;
Granillo, Alejandro;
Pouya, Nazanin;
Bhimraj, Adarsh;
Miller, William R.;
Tam, Vincent H.

Publication type:

Article

Utilization and associated factors of TPMT testing among Australian adults receiving thiopurines: A national retrospective data‐linkage study.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 12, doi. 10.1002/phar.4631

By:

Yiu, Chin Hang;
Ianni, Bella D.;
Fujita, Kenji;
Tan, Edwin C. K.;
Hilmer, Sarah N.;
Lu, Christine Y.

Publication type:

Article

Issue Information.

Published in:: Pharmacotherapy, 2025, v. 45, n. 1, p. 1, doi. 10.1002/phar.2815
Publication type:: Article

Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials.

Published in:

Pharmacotherapy, 2025, v. 45, n. 1, p. 43, doi. 10.1002/phar.4618

By:

Mitsuboshi, Satoru;
Morizumi, Makoto;
Imai, Shungo;
Hori, Satoko;
Kotake, Kazumasa

Publication type:

Article